Rational Design of Antisense Oligomers to Induce Dystrophin Exon Skipping

This publication has 44 references indexed in Scilit:

• By‐passing the nonsense mutation in the 4^CV mouse model of muscular dystrophy by induced exon skipping
  The Journal of Gene Medicine, 2008
• Antisense Oligonucleotide-induced Exon Skipping Across the Human Dystrophin Gene Transcript
  Molecular Therapy, 2007
• The Influence of Antisense Oligonucleotide Length on Dystrophin Exon Skipping
  Molecular Therapy, 2007
• Antisense oligonucleotide-induced exon skipping restores dystrophin expression in vitro in a canine model of DMD
  Gene Therapy, 2006
• Functional Analysis of 114 Exon-Internal AONs for Targeted DMD Exon Skipping: Indication for Steric Hindrance of SR Protein Binding Sites
  Oligonucleotides, 2005
• Targeted Exon Skipping in Transgenic hDMD Mice: A Model for Direct Preclinical Screening of Human-Specific Antisense Oligonucleotides
  Molecular Therapy, 2004
• Maximum Entropy Modeling of Short Sequence Motifs with Applications to RNA Splicing Signals
  Journal of Computational Biology, 2004
• Target selection for antisense oligonucleotide induced exon skipping in the dystrophin gene
  The Journal of Gene Medicine, 2003
• Improved antisense oligonucleotide induced exon skipping in the mdx mouse model of muscular dystrophy
  The Journal of Gene Medicine, 2002
• Listening to silence and understanding nonsense: exonic mutations that affect splicing
  Nature Reviews Genetics, 2002